Financial Results for the quarter and year ended March 31 2026

Revenue Growth 20pctPat Growth 25pctResults View source PDF Explain this filing

PARKHOSPS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.0%Reaction day

₹261.00

prior close

₹257.23

announcement price

In-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-3.1%-2.0% vs market

Hospital peers, median of 24sector-2.3%-2.8% vs sector

On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 2.8 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.5

10m

+2.3

15m

+0.6

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.0-3.1-2.0-2.3-2.8

Next day

-5.3-2.4-2.9-1.8-3.5

-5.1-2.2-2.9-1.4-3.7

-7.2-2.5-4.7-1.5-5.7

-8.0-3.8-4.2-2.5-5.6

-5.3-3.4-1.9-1.0-4.2

-2.0-1.8-0.2-0.6-1.4

15d

+9.6+0.1+9.5-2.5+12.0

+5.6+1.2+4.3+0.2+5.4

+11.2+7.9+3.3+5.2+6.0

+8.4+10.3-1.9+3.1+5.3

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Park Medi World Ltd reported strong financial results for FY26. On a consolidated basis, revenue from operations grew 20.5% to ₹16,793.56 million from ₹13,935.70 million in FY25. Profit after tax increased 27% to ₹2,738.57 million from ₹2,154.41 million. Basic EPS improved from ₹5.60 to ₹6.87. The company completed its IPO in December 2025, raising ₹7,700 million. During FY26, the company made three acquisitions totaling ₹2,850 million (KPS Wellness, SVPD Healthcare, and Mahip Hospital) and commenced a new 350-bed hospital in Panchkula in April 2026. The statutory auditors issued an unmodified (clean) opinion on both standalone and consolidated financial results. Consolidated operating cash flow was positive at ₹3,290.94 million.

Likely market impact

The company demonstrated robust growth with 20%+ revenue expansion and 27% PAT growth, indicating successful integration of recent acquisitions and organic growth. The clean audit opinion and positive cash flows are positive signals for shareholders. The stock listed in December 2025 and these results should support investor confidence.